Contagion Editorial Staff

Although the incidence of Chlamydia trachomatis infections remains high among young women (ages 14-24), new data presented at the US Centers for Disease Control and Prevention (CDC) 2018 STD Conference indicate that prevalence of the sexually-transmitted infection (STI) is decreasing.

The US Food and Drug Administration has approved Allergan's supplemental New Drug Application to expand the approved use of their cephalosporin / beta-lactamase inhibitor combo antibiotic, AVYCAZ (ceftazidime and avibactam), to include the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) caused by susceptible Gram-negative microorganisms.